Stamford, CT -- (SBWIRE) -- 12/05/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Oi SA (ADR) (NYSE:OIBR), Newcastle Investment Corp. (NYSE:NCT), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), Cellceutix Corp (OTCMKTS:CTIX).
Oi SA (ADR) (NYSE:OIBR) ended its recent business day with the gain of 8.86% and closed at the price of $1.72 after opening at $1.59. The stock traded during its last trading session with the total volume of 26.31 million shares, as compared to its average volume of .14 million shares. Oi S.A., through its subsidiaries, provides integrated telecommunication services for residential customers, companies, and governmental agencies in Brazil. It operates in three segments: Fixed-Line and Data Transmission Services, Mobile Services, and Other Services.
For How Long OIBR will Fight for Profitability? Read This Trend Analysis report
Newcastle Investment Corp. (NYSE:NCT) remained among the day decliners and traded with volume of 7.28 million shares in the last session, as compared to average volume of 4.94 million shares. In comparison with 52 week range of $4.70 - $12.49, it faced lowest price of $5.24 during the last trading session whereas its day highest price was $5.35. The company’s total market capitalization is $1.56 billion, along with 293.33 million shares outstanding. Newcastle Investment Corp. operates as a real estate investment and finance company in the United States. The company invests in and manages a portfolio consisting of real estate securities; loans; excess mortgage servicing rights; and real estate related assets.
Has NCT Found The Bottom And Ready To Gain Momentum? Find Out Here
Oncomed Pharmaceuticals Inc (NASDAQ:OMED) showed 2.86 million shares in volume during the last trading session, while the average trading volume remained 296,246.00 shares. The stock kicked off its trading session at $30.15 and closed at $29.65 after mounting 7.04%. OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs).
Will OMED Continue To Move Higher? Find Out Here
Cellceutix Corp (OTCMKTS:CTIX) stock traded during its last trading session with the total traded volume of 386,316.00 million shares versus its average volume of 156,226.00 shares. The company opened its trade at the price of $1.53 and its closing price was $1.48 after losing -3.90% for the day. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Will CTIX Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)